P D Zende1, M P Bankar, P S Kamble, A A Momin. 1. Assistant Professor, Department of Biochemistry, Institute of Medical Sciences & Research , Mayani, Tal- Khatav, District- Satara, Maharashtra, India .
Abstract
BACKGROUND & OBJECTIVES: Myocardial infarction and stroke are leading causes of death worldwide. Primarily, arteriosclerosis is responsible for these events. There is a strong family history suggesting a genetic cause. Apolipoprotein E (apo E) plays an important role in lipid metabolism. Apo E is polymorphic with three isoforms, ApoE2, ApoE3 and ApoE4; which translate into three alleles of the gene. Its polymorphism may be a risk determinant of atherosclerosis. METHODS: Lipoprotein concentrations were studied, in 100 myocardial infarction and 50 cerebrovascular stroke subjects and compared with age and sex matched controls. Genotypes for apo E isoforms (E2, E3, and E4) for all above subjects and age and sex matched controls were determined by Multiplex Amplification Refractory Mutation System PCR. RESULTS: There were statistically significant higher values of serum total cholesterol and LDL cholesterol in study group, as compared to control group. Study of Apo E isoforms revealed higher proportion of E4 allele in the study group as compared to control group. The occurrence of each allele frequency in study and control group was E4E4: 28.66% and 16.0%, E3E3: 39.33% and 56.66%, E4E3: 14.66% and 9.33%, E3E2: 8.66% and 10.66%, E4E2: 4.66% and 2.66% & for E2E2: 4.0% and 4.66% respectively. INTERPRETATION & CONCLUSION: There were significantly higher levels of serum total cholesterol, LDL cholesterol and triglyceride with E4 allele; when compared with in the study group and between study group and control group. Apo E polymorphism influences serum lipid levels and is an independent risk determinant of arteriosclerosis.
BACKGROUND & OBJECTIVES:Myocardial infarction and stroke are leading causes of death worldwide. Primarily, arteriosclerosis is responsible for these events. There is a strong family history suggesting a genetic cause. Apolipoprotein E (apo E) plays an important role in lipid metabolism. Apo E is polymorphic with three isoforms, ApoE2, ApoE3 and ApoE4; which translate into three alleles of the gene. Its polymorphism may be a risk determinant of atherosclerosis. METHODS: Lipoprotein concentrations were studied, in 100 myocardial infarction and 50 cerebrovascular stroke subjects and compared with age and sex matched controls. Genotypes for apo E isoforms (E2, E3, and E4) for all above subjects and age and sex matched controls were determined by Multiplex Amplification Refractory Mutation System PCR. RESULTS: There were statistically significant higher values of serum total cholesterol and LDL cholesterol in study group, as compared to control group. Study of Apo E isoforms revealed higher proportion of E4 allele in the study group as compared to control group. The occurrence of each allele frequency in study and control group was E4E4: 28.66% and 16.0%, E3E3: 39.33% and 56.66%, E4E3: 14.66% and 9.33%, E3E2: 8.66% and 10.66%, E4E2: 4.66% and 2.66% & for E2E2: 4.0% and 4.66% respectively. INTERPRETATION & CONCLUSION: There were significantly higher levels of serum total cholesterol, LDL cholesterol and triglyceride with E4 allele; when compared with in the study group and between study group and control group. Apo E polymorphism influences serum lipid levels and is an independent risk determinant of arteriosclerosis.
Authors: A Mendes-Lana; G G Pena; S N Freitas; A A Lima; R L C Nicolato; R M Nascimento-Neto; G L L Machado-Coelho; R N Freitas Journal: Braz J Med Biol Res Date: 2007-01 Impact factor: 2.590
Authors: C R Newton; N Kalsheker; A Graham; S Powell; A Gammack; J Riley; A F Markham Journal: Nucleic Acids Res Date: 1988-09-12 Impact factor: 16.971
Authors: S Lehtinen; T Lehtimäki; T Sisto; J P Salenius; M Nikkilä; H Jokela; T Koivula; F Ebeling; C Ehnholm Journal: Atherosclerosis Date: 1995-04-07 Impact factor: 5.162
Authors: Andrei Alkmim Teixeira; Mauro Sergio Marrocos; Beata Marie Redublo Quinto; Maria Aparecida Dalboni; Cassio Jose de Oliveira Rodrigues; Silmara de Melo Carmona; Mariana Kuniyoshi; Marcelo Costa Batista Journal: Lipids Health Dis Date: 2014-11-20 Impact factor: 3.876
Authors: Jesús de Pedro-Cuesta; Pablo Martínez-Martín; Alberto Rábano; Enrique Alcalde-Cabero; Fernando José García López; Javier Almazán-Isla; María Ruiz-Tovar; Maria-José Medrano; Fuencisla Avellanal; Olga Calero; Miguel Calero Journal: J Alzheimers Dis Date: 2016 Impact factor: 4.472
Authors: Jesús de Pedro-Cuesta; Pablo Martínez-Martín; Alberto Rábano; María Ruiz-Tovar; Enrique Alcalde-Cabero; Miguel Calero Journal: Front Aging Neurosci Date: 2016-06-13 Impact factor: 5.750